Te Niwha is New Zealand's Infectious Diseases Research Platform, funded by the New Zealand Government to enable better preparedness and response to threats from infectious disease.
Our vision is to ensure Aotearoa New Zealand's response to current, ongoing and emerging infectious disease threats is strong, prepared and unified.
Our mission is to ensure that Aotearoa New Zealand has world-class research capability to support our preparedness for current and future infectious disease challenges.
Ngā Rangahau Matua Research Priorities
Ngā Kaupapa Rau Recent Updates
Matauranga Publication
As the Te Niwha funded research progresses, publications are starting to come out. You can now follow Te Niwha’s Google Scholar page to keep up to date with new publications from our researchers.
LATEST PUBLICATIONS:
Ngā Pourangahau Research Leaders
![]() |
![]() |
|
CONTRACT HOLDER >> Wastewater Testing at the Border & Building >> Rapid testing for infectious diseases in the community >> Strengthening public health surveillance of emerging diseases for communities and Māori >> Community-based Carriage study >> Water security risks from responding to HPAI and other livestock emerging diseases |
RESEARCH PARTNER >> Influenza-like Illnesses - Detection and Monitoring In Community Pharmacies >> A genomics-informed approach to avian influenza virus surveillance |
![]() |
|
|
CONTRACT HOLDER >> Broad-spectrum antiviral potential within anti-cancer drugs >> Preventing recurrent admissions for preschool wheeze respiratory infections – ARROW (Strategic) >> Te Whata Kura - a national antibiotic guideline for Aotearoa >> Pacific Youth, Infectious Disease Risk, and Social Media in Aotearoa |
RESEARCH PARTNER >> Wastewater Testing at the Border & Building >> Reducing barriers, improving lives: A new approach to rheumatic fever treatment> >> Community-based Carriage Study >> Exploring new anti-microbial agents >> Tāngata Whaikaha Māori Probabilistic Panel Survey Research |
![]() |
![]() |
|
CONTRIBUTOR |
CONTRIBUTOR >> Finding the best treatments for severe influenza >> COVID-19 Needle Length Study >> Influenza-like Illnesses - Detection and monitoring In Community Pharmacies |
![]() |
![]() |
|
CONTRIBUTOR >> Exploring new anti-microbial agents >> Rapid point-of-use testing for infectious diseases in the community >> A genomics-informed approach to avian influenza virus surveillance |
CONTRIBUTOR >> Māngai Wai Māori: Ngāi Tahu drinking water programme |
|
OTHER CONTRACT HOLDERS |
|||
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
Ohu Rangahau Research Partners
![]() |
![]() |
|
>> Reducing barriers, improving lives: A new approach to rheumatic fever treatment |
>> AMR reference laboratory and pathogen genomics capability for Fiji |
![]() |
|
|
>> Tāngata Whaikaha Māori Probabilistic Panel Survey Research |
>> Broad-spectrum antiviral development of PI3K inhibitor compounds |
![]() |
|
|
>> Pacific Youth, Infectious Disease Risk, and Social Media in Aotearoa |
![]() |
|
|
>> Reducing barriers, improving lives: A new approach to rheumatic fever treatment |
|
















































